279 related articles for article (PubMed ID: 21720271)
1. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21.
Zhang Y; Wang Y; Wang X; Zhang Y; Eisner GM; Asico LD; Jose PA; Zeng C
J Hypertens; 2011 Aug; 29(8):1560-8. PubMed ID: 21720271
[TBL] [Abstract][Full Text] [Related]
2. The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell.
Kim HS; Cho HJ; Cho HJ; Park SJ; Park KW; Chae IH; Oh BH; Park YB; Lee MM
J Mol Cell Cardiol; 2004 Oct; 37(4):871-80. PubMed ID: 15380677
[TBL] [Abstract][Full Text] [Related]
3. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
4. MiR-21 inhibits c-Ski signaling to promote the proliferation of rat vascular smooth muscle cells.
Li J; Zhao L; He X; Yang T; Yang K
Cell Signal; 2014 Apr; 26(4):724-9. PubMed ID: 24388835
[TBL] [Abstract][Full Text] [Related]
5. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
[TBL] [Abstract][Full Text] [Related]
6. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension.
Wu WH; Hu CP; Chen XP; Zhang WF; Li XW; Xiong XM; Li YJ
Am J Hypertens; 2011 Oct; 24(10):1087-93. PubMed ID: 21753805
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim HM; Bae SJ; Kim DW; Kim BK; Lee SB; Lee US; Kim CH; Moon SK
Int Immunopharmacol; 2007 Aug; 7(8):1083-91. PubMed ID: 17570325
[TBL] [Abstract][Full Text] [Related]
9. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression.
Kee HJ; Park S; Kwon JS; Choe N; Ahn Y; Kook H; Jeong MH
FEBS Lett; 2013 Aug; 587(15):2385-92. PubMed ID: 23770100
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation.
Sekiya Y; Ogawa T; Iizuka M; Yoshizato K; Ikeda K; Kawada N
J Cell Physiol; 2011 Oct; 226(10):2535-42. PubMed ID: 21792910
[TBL] [Abstract][Full Text] [Related]
12. Protective role of a novel erythrocyte-derived depressing factor on blood vessels of renovascular hypertensive rats.
Pang H; Wen YY; Ma N; Wang YT; Shi L
Clin Exp Pharmacol Physiol; 2007; 34(5-6):393-8. PubMed ID: 17439406
[TBL] [Abstract][Full Text] [Related]
13. β-Sitosterol inhibits cell cycle progression of rat aortic smooth muscle cells through increases of p21cip1 protein.
Chien MH; Lee TS; Liang YC; Lee WS
J Agric Food Chem; 2010 Sep; 58(18):10064-9. PubMed ID: 20731356
[TBL] [Abstract][Full Text] [Related]
14. Raphanus sativus and its isothiocyanates inhibit vascular smooth muscle cells proliferation and induce G(1) cell cycle arrest.
Suh SJ; Moon SK; Kim CH
Int Immunopharmacol; 2006 May; 6(5):854-61. PubMed ID: 16546717
[TBL] [Abstract][Full Text] [Related]
15. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9.
Suh SJ; Jin UH; Kim SH; Chang HW; Son JK; Lee SH; Son KH; Kim CH
J Cell Biochem; 2006 Dec; 99(5):1298-307. PubMed ID: 16795041
[TBL] [Abstract][Full Text] [Related]
16. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
Bond M; Sala-Newby GB; Wu YJ; Newby AC
Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
[TBL] [Abstract][Full Text] [Related]
17. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim CH; Moon SK
Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
[TBL] [Abstract][Full Text] [Related]
19. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells.
Wassmann S; Wassmann K; Jung A; Velten M; Knuefermann P; Petoumenos V; Becher U; Werner C; Mueller C; Nickenig G
J Mol Cell Cardiol; 2007 Sep; 43(3):301-7. PubMed ID: 17659301
[TBL] [Abstract][Full Text] [Related]
20. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase.
Moon SK; Jung SY; Choi YH; Lee YC; Patterson C; Kim CH
J Cell Physiol; 2004 Feb; 198(2):310-23. PubMed ID: 14603533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
